These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6710555)

  • 41. Abnormal theophylline levels in plasma by fluorescence polarization immunoassay in patients with renal disease.
    Patel JA; Clayton LT; LeBel CP; McClatchey KD
    Ther Drug Monit; 1984; 6(4):458-60. PubMed ID: 6515707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma.
    Jolley ME
    J Anal Toxicol; 1981; 5(5):236-40. PubMed ID: 7321548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenytoin immunoassay measurements in serum samples from patients with renal insufficiency: comparison with high-performance liquid chromatography.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    J Clin Lab Anal; 2007; 21(2):119-23. PubMed ID: 17385679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of the Abbott TDx lidocaine, phenytoin, and phenobarbital assays to postmortem blood specimens.
    Caplan YH; Levine B
    J Anal Toxicol; 1988; 12(5):265-7. PubMed ID: 3066993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein.
    Chen BH; Taylor EH; Pappas AA
    Clin Chim Acta; 1987 Feb; 163(1):75-80. PubMed ID: 3552331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of theophylline in saliva, using fluorescence polarization immunoassay (FPIA).
    Niemann A; Oellerich M; Schumann G; Sybrecht GW
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):725-32. PubMed ID: 3910758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
    Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
    J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 49. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassay.
    Matzke GR; Sawchuk RJ
    Drug Intell Clin Pharm; 1981 May; 15(5):386-8. PubMed ID: 7023901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
    Haver VM; Audino N; Burris S; Nelson M
    Clin Chem; 1989 Jan; 35(1):138-40. PubMed ID: 2463117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of free desipramine in serum by ultrafiltration with immunoassay.
    Hursting MJ; Clark GD; Raisys VA; Miller SJ; Opheim KE
    Clin Chem; 1992 Dec; 38(12):2468-71. PubMed ID: 1458586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
    Pospisil J; Pelclová D
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenytoin can be measured reliably in uremic patients by immunoassay.
    Green PJ; Vlasses PH; Frauenhoffer SM; Hennessey KM; Rocci ML
    Clin Chem; 1983 Apr; 29(4):737. PubMed ID: 6831721
    [No Abstract]   [Full Text] [Related]  

  • 57. Endogenous drug-like factors in a Polish population.
    Mrozikiewicz A; Lowicki Z; Kowal J; Mrozikiewicz PM
    Pol J Pharmacol; 1994; 46(3):179-80. PubMed ID: 8000451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system.
    Vogeser M; Möhnle P; Briegel J
    Clin Chem Lab Med; 2007; 45(4):521-5. PubMed ID: 17439331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated homogeneous liposome immunoassay systems for anticonvulsant drugs.
    Kubotsu K; Goto S; Fujita M; Tuchiya H; Kida M; Takano S; Matsuura S; Sakurabayashi I
    Clin Chem; 1992 Jun; 38(6):808-12. PubMed ID: 1597006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.